Enterprise Value

25.01M

Cash

44.98M

Avg Qtr Burn

-13.92M

Short % of Float

2.42%

Insider Ownership

13.42%

Institutional Own.

41.72%

Qtr Updated

03/31/23


Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & IndicationStage & EventCatalyst Date
ONCR-177 Details
Solid tumor/s, Melanoma, Cancer, Breast cancer, Head and neck squamous cell carcinoma

Failed

Discontinued